Serum soluble ST2 is a potential long-term prognostic biomarker for transient ischaemic attack and ischaemic stroke.,European Journal of Neurology

当前位置： X-MOL 学术 › Eur. J. Neurol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Serum soluble ST2 is a potential long-term prognostic biomarker for transient ischaemic attack and ischaemic stroke.
European Journal of Neurology ( IF 4.5 ) Pub Date : 2020-06-27 , DOI: 10.1111/ene.14419
X Tian _{1,

2} , Y Guo _{1,

2} , X Wang _{1,

2} , L Pei _{1,

2} , X Wang _{1,

2} , J Wu _{1,

2} , S Sun _{1,

2} , Y Li _{1,

2} , M Ning ₃ , F S Buonanno ₃ , Y Xu _{1,

2} , B Song _{1,

2}

Affiliation

Soluble ST2 (sST2) is a promising biomarker in inflammation, atherosclerosis and cardiovascular diseases. We investigated the association between serum sST2 and poor outcome in patients with transient ischaemic attack (TIA)/ischaemic stroke.

中文翻译：